Marc Roberts M.D. P.A.
Marc Roberts M.D. P.A. was paid $3.88M by Medicaid between Jan 2018 and Dec 2024, across 57 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 54% of everything it billed.
33Billing provider infoMARC ROBERTS M.D. P.A.
NEWARK, NJ 07102
NEWARK, NJ 07102
33aNPI1801956818assigned 12/11/2006
33bProvider typeSpecialist
28Total paid$3.88M
24GClaims290,393
24DCodes billed57
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in New Jersey
Rank by total paid#15 of 378
Median peer was paid$63K
This provider vs. median62×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 68,868 | $1.01M | |
| 2019 | 68,907 | $1.05M | |
| 2020 | 54,200 | $776K | |
| 2021 | 55,488 | $699K | |
| 2022 | 19,324 | $152K | |
| 2023 | 398 | $0.00 | |
| 2024incomplete | 23,208 | $191K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 54% | 86,163 | 73,598 | $2.10M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 9.1% | 28,400 | 27,800 | $354K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 7.3% | 14,742 | 14,377 | $285K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.9% | 9,687 | 9,555 | $228K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.2% | 7,070 | 6,957 | $164K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.1% | 6,069 | 5,930 | $158K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.3% | 3,213 | 3,140 | $89K |
| 3008F | 2.1% | 21,861 | 21,286 | $81K | |
| 83655 | 1.7% | 6,566 | 6,414 | $65K | |
| 86580 | 1.6% | 22,223 | 22,169 | $62K | |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 33,601 | 29,477 | $60K |
| 90670 | <1% | 1,293 | 1,240 | $30K |
45 more codes
| 90473 | <1% | 1,952 | $24K | |
| 99381 | <1% | 719 | $24K | |
| 90656 | <1% | 6,314 | $23K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 821 | $16K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 293 | $16K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 687 | $15K |
| 36406 | <1% | 2,453 | $14K | |
| 90734 | <1% | 715 | $10K | |
| 90651 | <1% | 751 | $10K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 327 | $7K |
| 90620 | <1% | 325 | $6K | |
| 97803 | <1% | 22,586 | $5K | |
| 90671 | <1% | 334 | $5K | |
| 90723 | <1% | 872 | $5K | |
| 99383 | <1% | 153 | $3K | |
| 90710 | <1% | 182 | $3K | |
| 99382 | <1% | 145 | $2K | |
| 92551 | <1% | 430 | $2K | |
| 90672 | <1% | 1,006 | $1K | |
| 90633 | <1% | 599 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 301 | $992.35 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 279 | $963.96 |
| 90648 | <1% | 817 | $712.51 | |
| 99177 | <1% | 691 | $686.40 | |
| 90655 | <1% | 697 | $651.31 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 134 | $636.36 |
| 90680 | <1% | 349 | $600.88 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 101 | $594.00 |
| 90696 | <1% | 136 | $472.71 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 103 | $438.57 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 178 | $328.74 |
| 90715 | <1% | 134 | $288.70 | |
| 99174 | <1% | 113 | $171.42 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 85 | $153.36 |
| 36410 | <1% | 163 | $134.94 | |
| 90716 | <1% | 89 | $129.98 | |
| 99000 | <1% | 2,891 | $91.52 | |
| 99188 | <1% | 41 | $70.00 | |
| H0033 | Oral medication administration, direct observation | <1% | 41 | $40.00 |
| 99173 | <1% | 228 | $10.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 12 | $4.00 |
| 90681 | <1% | 71 | $1.03 | |
| 90698 | 0% | 14 | $0.00 | |
| 90647 | 0% | 158 | $0.00 | |
| 99070 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROBERTS, MARC (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Washington Park Pediatrics | Newark, NJ | $1.31M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.